Wu Y, Ma L, Li X, Yang J, Rao X, Hu Y
Front Pharmacol. 2024; 15:1459954.
PMID: 39679365
PMC: 11637864.
DOI: 10.3389/fphar.2024.1459954.
Rachamim M, Domb A, Goldblum A
ACS Omega. 2024; 9(42):42709-42720.
PMID: 39464471
PMC: 11500160.
DOI: 10.1021/acsomega.4c01070.
Xu K, Zhong J, Li J, Cao Y, Wei L
Front Mol Biosci. 2024; 11:1472252.
PMID: 39398278
PMC: 11467476.
DOI: 10.3389/fmolb.2024.1472252.
da Silva Lopes F, Lucio F, da Rocha M, Oliveira V, Alexandre Roberto C, Marinho M
3 Biotech. 2024; 14(5):135.
PMID: 38665880
PMC: 11039600.
DOI: 10.1007/s13205-024-03978-9.
Gallardo A, Gutierrez M, Gomez L, Delos Reyes P, Dones S, Dumbrique M
Asian Pac J Cancer Prev. 2024; 25(3):839-856.
PMID: 38546067
PMC: 11152392.
DOI: 10.31557/APJCP.2024.25.3.839.
Computational investigation of turmeric phytochemicals targeting PTR1 enzyme of species.
Ullah W, Wu W, Malak N, Nasreen N, Swelum A, Marcelino L
Heliyon. 2024; 10(6):e27907.
PMID: 38533011
PMC: 10963314.
DOI: 10.1016/j.heliyon.2024.e27907.
Orphan GPR52 as an emerging neurotherapeutic target.
Ali S, Wang P, Murphy R, Allen J, Zhou J
Drug Discov Today. 2024; 29(4):103922.
PMID: 38387741
PMC: 11416161.
DOI: 10.1016/j.drudis.2024.103922.
Anxiolytic- Effects by -Ferulic Acid Possibly Occur through GABAergic Interaction Pathways.
Bhuia M, Rokonuzzman M, Hossain M, Ansari S, Ansari I, Islam T
Pharmaceuticals (Basel). 2023; 16(9).
PMID: 37765079
PMC: 10535412.
DOI: 10.3390/ph16091271.
QSAR Studies and Scaffold Optimization of Predicted Novel ACC 2 Inhibitors to Treat Metabolic Syndrome.
Madan K, Paliwal S, Sharma S, Kesar S, Chauhan N, Madan M
Curr Drug Discov Technol. 2023; 21(2):e010923220643.
PMID: 37680153
DOI: 10.2174/1570163820666230901144003.
Antidiarrheal Potential of : In Vivo and In Silico Approaches.
Ahmad I, Alotaibi B, Malak N, Asad F, Ullah B, Nasreen N
Pharmaceuticals (Basel). 2023; 16(4).
PMID: 37111246
PMC: 10143657.
DOI: 10.3390/ph16040489.
Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach.
Akash S, Hossain A, Hossain M, Rahman M, Ahmed M, Ali N
Front Cell Infect Microbiol. 2023; 13:1157627.
PMID: 37033493
PMC: 10073709.
DOI: 10.3389/fcimb.2023.1157627.
Ligand and structure-based approaches for the exploration of structure-activity relationships of fusidic acid derivatives as antibacterial agents.
Zheng W, Tu B, Zhang Z, Li J, Yan Z, Su K
Front Chem. 2023; 10:1094841.
PMID: 36688047
PMC: 9852990.
DOI: 10.3389/fchem.2022.1094841.
: A Versatile Workflow for the Generation of Receptor-based Pharmacophore Models for Virtual Screening.
Heider J, Kilian J, Garifulina A, Hering S, Langer T, Seidel T
J Chem Inf Model. 2022; 63(1):101-110.
PMID: 36526584
PMC: 9832483.
DOI: 10.1021/acs.jcim.2c00814.
Molecular docking analysis of lupeol with different cancer targets.
Gunasekaran M, Ravi R, Subramanian K
Bioinformation. 2022; 18(3):134-140.
PMID: 36518133
PMC: 9722432.
DOI: 10.6026/97320630018134.
Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century.
Campos-Almazan M, Hernandez-Campos A, Castillo R, Sierra-Campos E, Valdez-Solana M, Avitia-Dominguez C
Pharmaceuticals (Basel). 2022; 15(7).
PMID: 35890163
PMC: 9322956.
DOI: 10.3390/ph15070866.
Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy.
Wang X, Lu X, Yan D, Zhou Y, Tan X
Int J Mol Sci. 2022; 23(13).
PMID: 35806118
PMC: 9266353.
DOI: 10.3390/ijms23137104.
Drug Repurposing Targeting MvfR Using Docking, Virtual Screening, Molecular Dynamics, and Free-Energy Calculations.
Vieira T, Magalhaes R, Simoes M, Sousa S
Antibiotics (Basel). 2022; 11(2).
PMID: 35203788
PMC: 8868191.
DOI: 10.3390/antibiotics11020185.
Magnetic Ligand Fishing Using Immobilized Cyclooxygenase-2 for Identification and Screening of Anticoronary Heart Disease Ligands From .
Chi M, Wang H, Yan Z, Cao L, Gao X, Qin K
Front Nutr. 2022; 8:794193.
PMID: 35174196
PMC: 8841743.
DOI: 10.3389/fnut.2021.794193.
In Silico Identification of Possible Inhibitors for Protein Kinase B (PknB) of .
Vieira T, Martins F, Moreira J, Barbosa T, Sousa S
Molecules. 2021; 26(20).
PMID: 34684743
PMC: 8541300.
DOI: 10.3390/molecules26206162.
Improving Structure-Based Virtual Screening with Ensemble Docking and Machine Learning.
Ricci-Lopez J, Aguila S, Gilson M, Brizuela C
J Chem Inf Model. 2021; 61(11):5362-5376.
PMID: 34652141
PMC: 8865842.
DOI: 10.1021/acs.jcim.1c00511.